The design, synthesis, and biological evaluation of nitrido technetium-99m complexes for imagingbenzodiazepine receptors are described. The design was performed by selecting the precursorbiologically active substrate desmethyldiazepam, and the reactive metal-containing fragment [
99mTc(N)(PXP)]
2+ (PXP = diphosphine ligand) as molecular building-blocks for assembling the structure ofthe final radiopharmaceuticals through the application of the so-called 'bifunctional' and 'integrated'approaches. This required the synthesis of the ligands H
2BZ1, H
2C1, and H
2C2 (Figures 1 and 2)derived from desmethyldiazepam. In turn, these ligands were reacted with [
99mTc(N)(PXP)]
2+ to affordthe complexes [
99mTc(N)(PXP)(L)] (L = BZ1, C1, C2). The chemical nature of the resulting Tc-99mradiopharmaceuticals was investigated using chromatographic methods, and by comparison with theanalogous complexes prepared with the long-lived isotope Tc-99g and characterized by spectroscopicand analytical methods. Results showed that the complexes [
99mTc(N)(PXP)(L)] are neutral and possessan asymmetrical five-coordinated structure in which two different bidentate ligands, PXP and L, arecoordinated to the same Tc
![](/images/entities/tbd1.gif)
N core. With the ligand H
2BZ1, two isomers were obtained depending onthe syn or anti orientation of the pendant benzodiazepine group relative to the Tc
![](/images/entities/tbd1.gif)
N multiple bond.Biodistribution studies of Tc-99m complexes were carried out in rats, and affinity for benzodiazepinereceptors was assessed through in vitro binding experiments on isolated rat's cerebral membranesusing the corresponding Tc-99g complexes.